These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17419693)

  • 1. Sclerodermatous graft-versus-host disease: clinical spectrum and therapeutic challenges.
    White JM; Creamer D; du Vivier AW; Pagliuca A; Ho AY; Devereux S; Salisbury JR; Mufti GJ
    Br J Dermatol; 2007 May; 156(5):1032-8. PubMed ID: 17419693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease.
    Calzavara Pinton P; Porta F; Izzi T; Venturini M; Capezzera R; Zane C; Notarangelo LD
    Haematologica; 2003 Oct; 88(10):1169-75. PubMed ID: 14555314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
    Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
    Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Koebnerizing sclerodermatous graft-versus-host disease caused by donor lymphocyte infusion and interferon-alpha.
    White JM; Devereux S; Pagliuca A; Salisbury JR; du Vivier AW; Creamer D
    Br J Dermatol; 2006 Sep; 155(3):621-3. PubMed ID: 16911292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis.
    Owsianowski M; Gollnick H; Siegert W; Schwerdtfeger R; Orfanos CE
    Bone Marrow Transplant; 1994 Nov; 14(5):845-8. PubMed ID: 7889018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy.
    Hoffner MV; Carrizosa Esquivel A; Pulpillo Ruiz A; Herrera Saval A; Conejo-Mir J; Camacho FM
    J Drugs Dermatol; 2009 Nov; 8(11):1027-9. PubMed ID: 19894371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerodermatous chronic graft-versus-host disease--a report of four pediatric cases.
    Tolland JP; Devereux C; Jones FC; Bingham EA
    Pediatr Dermatol; 2008; 25(2):240-4. PubMed ID: 18429789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis.
    Komanduri KV; Couriel D; Champlin RE
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):1-6. PubMed ID: 16399595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal photopheresis in graft-versus-host disease.
    Carcagnì MR; De Aloe G; D'Ascenzo G; Rubegni P; Fimiani M
    J Dtsch Dermatol Ges; 2008 Jun; 6(6):451-7. PubMed ID: 18177413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
    Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
    Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy by allogeneic stem cell transplantation.
    Ringdén O
    Adv Cancer Res; 2007; 97():25-60. PubMed ID: 17419940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA).
    Vogelsang GB; Wolff D; Altomonte V; Farmer E; Morison WL; Corio R; Horn T
    Bone Marrow Transplant; 1996 Jun; 17(6):1061-7. PubMed ID: 8807115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PUVA-bath photochemotherapy and isotretinoin in sclerodermatous graft-versus-host disease.
    Ghoreschi K; Thomas P; Penovici M; Ullmann J; Sander CA; Ledderose G; Plewig G; Kolb HJ; Röcken M
    Eur J Dermatol; 2008; 18(6):667-70. PubMed ID: 18955201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-tumor effect of allogeneic bone marrow/stem cell transplant without graft vs. host disease toxicity and without a matched donor requirement?
    Har-Noy M; Slavin S
    Med Hypotheses; 2008; 70(6):1186-92. PubMed ID: 18054441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of sclerodermatous graft-versus-host disease following autologous peripheral blood stem cell transplantation.
    Nakamura K; Kawakami Y; Oyama N; Kaneko F; Abe H; Sagara H; Ohto H
    J Dermatol; 2006 Feb; 33(2):135-8. PubMed ID: 16556284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UV treatment of chronic skin graft-versus-host disease--focus on UVA1 and extracorporeal photopheresis.
    Greinix HT; Tanew A
    Curr Probl Dermatol; 2012; 43():116-31. PubMed ID: 22377925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of late graft-versus-host disease in a patient post-allogeneic stem cell transplantation by progesterone in conjunction with donor lymphocyte infusion.
    Gesundheit B; Shapira MY; Maly A; Samuel S; Budowski E; Or R
    Leuk Res; 2008 Mar; 32(3):501-3. PubMed ID: 17727947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of rituximab in chronic graft-versus-host disease.
    Bates JS; Engemann AM; Hammond JM
    Ann Pharmacother; 2009 Feb; 43(2):316-21. PubMed ID: 19193571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.